Glenmark recalls 6,528 bottles of blood pressure drug in US
Enforcement Report - Week of April 10, 2024
Enforcement Report - Week of April 3, 2024
Enforcement Report - Week of May 31, 2023
ScieGen's Generic Diltiazem Hydrochloride Receives Approval in the U.S.
Eugia's Generic Diltiazem Hydrochloride Receives Approval in the U.S.
Enforcement Report - Week of March 8, 2023
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing. As per the US Food and Drug Administration's Enforcement Report, the US-based arm of Sun Pharmaceutical Industries is recalling lots of Diltiazem Hydrochloride extended-release capsules which are used to treat angina, high blood pressure and some types of irregular heartbeats.
Enforcement Report - Week of February 8, 2023